During the past decade, New Zealand Brain Research Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Zealand Brain Research Institute" #1 sponsor was "Theravance Biopharma" with 3 trials, followed by "Alterity Therapeutics" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Massachusetts General Hospital" with 1 trials sponsored and "Wave Life Sciences Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Zealand Brain Research Institute" #1 collaborator was "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New Zealand Brain Research Institute" are "Symptomatic Neurogenic Orthostatic Hypotension" (3 trials), "ALS" (1 trials), "FTD" (1 trials), "Huntington's Disease" (1 trials) and "Huntingtons Disease" (1 trials). Many other conditions were trialed in "New Zealand Brain Research Institute" in a lesser frequency.

Most popular intervention types in "New Zealand Brain Research Institute" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ampreloxetine" (3 trials), "ATH434 dose level 1" (1 trials), "ATH434 dose level 2" (1 trials) and "Creatine Monohydrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Zealand Brain Research Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "New Zealand Brain Research Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in New Zealand Brain Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in New Zealand Brain Research Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".